Schmidt Christian, Christian Laura, Smith Tyler A, Tidwell Josephine, Kim Dongkyoon, Tucker Haley O
Department of Molecular Biosciences, the University of Texas at Austin, Austin, TX 78712, USA.
Department of Biomaterials and Healthcare, Division of Life Science and Bioprocesses, Fraunhofer-Institute for Applied Polymer Research (IAP), 14476 Potsdam-Golm, Germany.
Diseases. 2021 Mar 20;9(1):22. doi: 10.3390/diseases9010022.
Several diseases originate via dysregulation of the actin cytoskeleton. The ARID3A/Bright transcription factor has also been implicated in malignancies, primarily those derived from hematopoietic lineages. Previously, we demonstrated that ARID3A shuttles between the nucleus and the plasma membrane, where it localizes within lipid rafts. There it interacts with components of the B-cell receptor (BCR) to reduce its ability to transmit downstream signaling. We demonstrate here that a direct component of ARID3A-regulated BCR signal strength is cortical actin. ARID3A interacts with actin exclusively within lipid rafts via the actin-binding protein EZRIN, which confines unstimulated BCRs within lipid rafts. BCR ligation discharges the ARID3A-EZRIN complex from lipid rafts, allowing the BCR to initiate downstream signaling events. The ARID3A-EZRIN interaction occurs almost exclusively within unpolymerized G-actin, where EZRIN interacts with the multifunctional ARID3A REKLES domain. These observations provide a mechanism by which a transcription factor directly regulates BCR signaling via linkage to the actin cytoskeleton with consequences for B-cell-related neoplasia.
几种疾病是由肌动蛋白细胞骨架失调引发的。ARID3A/Bright转录因子也与恶性肿瘤有关,主要是那些源自造血谱系的肿瘤。此前,我们证明ARID3A在细胞核和质膜之间穿梭,它定位于脂筏内。在那里,它与B细胞受体(BCR)的成分相互作用,以降低其传递下游信号的能力。我们在此证明,ARID3A调节的BCR信号强度的直接成分是皮层肌动蛋白。ARID3A通过肌动蛋白结合蛋白埃兹蛋白(EZRIN)仅在脂筏内与肌动蛋白相互作用,这将未受刺激的BCR限制在脂筏内。BCR连接使ARID3A-EZRIN复合物从脂筏中释放出来,使BCR能够启动下游信号事件。ARID3A-EZRIN相互作用几乎只发生在未聚合的G-肌动蛋白内,其中EZRIN与多功能ARID3A REKLES结构域相互作用。这些观察结果提供了一种机制,即转录因子通过与肌动蛋白细胞骨架相连直接调节BCR信号,这对B细胞相关肿瘤形成具有影响。